Sulfur(VI) fluoride compounds and methods for the preparation thereof

US10117840B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10117840-B2
Application numberUS-201515316742-A
CountryUS
Kind codeB2
Filing dateJun 5, 2015
Priority dateJun 6, 2014
Publication dateNov 6, 2018
Grant dateNov 6, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This application describes a compound represented by Formula (I): (I) wherein: Y is a biologically active organic core group comprising one or more of an aryl group, a heteroaryl aryl group, a nonaromatic hydrocarbyl group, and a nonaromatic heterocyclic group, to which Z is covalently bonded; n is 1, 2, 3, 4 or 5; m is 1 or 2; Z is O, NR, or N; X 1 is a covalent bond or —CH 2 CH 2 —, X 2 is O or NR; and R comprises H or a substituted or unsubstituted group selected from an aryl group, a heteroaryl aryl group, a nonaromatic hydrocarbyl group, and a nonaromatic heterocyclic group. Methods of preparing the compounds, methods of using the compounds, and pharmaceutical compositions comprising the compounds are described as well.

First claim

Opening claim text (preview).

We claim: 1. An amino protected O-fluorosulfonyl-L-tyrosine of formula: wherein “Fmoc” represents a 9-fluorenylmethyloxycarbonyl protecting group. 2. A polypeptide comprising an O-fluorosulfonyl-L-tyrosine residue. 3. The polypeptide of claim 2 , wherein the polypeptide is selected from the group consisting of oxytocin, indolicin, thymopentin, and arginine vassopressin, in which the tyrosine residue thereof is replaced by an O-fluorosulfonyl-L-tyrosine residue. 4. A method of preparing a sulfated polypeptide comprising contacting the polypeptide of claim 2 with cesium carbonate and a solution of ammonia in methanol to selectively hydrolyze the fluoro group of the fluorosulfonyl-L-tyrosine residue and from a sulfated tyrosine residue therefrom.

Assignees

Inventors

Classifications

  • condensed with carbocyclic rings or ring systems · CPC title

  • of the sex hormones · CPC title

  • Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

  • of the suprarenal hormones · CPC title

  • Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10117840B2 cover?
This application describes a compound represented by Formula (I): (I) wherein: Y is a biologically active organic core group comprising one or more of an aryl group, a heteroaryl aryl group, a nonaromatic hydrocarbyl group, and a nonaromatic heterocyclic group, to which Z is covalently bonded; n is 1, 2, 3, 4 or 5; m is 1 or 2; Z is O, NR, or N; X 1 is a covalent bond or —CH 2 CH 2 —, X 2 is …
Who is the assignee on this patent?
Scripps Research Inst
What technology area does this patent fall under?
Primary CPC classification A61K31/05. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).